Burns F J, Albert R E
Cancer Detect Prev. 1981;4(1-4):99-107.
An analysis is presented for evaluating the potency of initiators, promoters, and carcinogens based on the number of tumors that occur as a function of dose and time when compounds are applied topically in an appropriate solvent to mouse skin. A given compound was tested as an initiator (a single dose followed by prolonged promotion), as a whole carcinogen (multiple applications for a prolonged period of time), and as a cocarcinogen (multiple applications for a prolonged period of time in combination with promotion). Compounds tested were 7,12 dimethylbenz(a)anthracene (DMBA), benzo(a)pyrene (B(a)P), 4-nitroquinoline-1-oxide (4-NQO), and betapropriolactone (BPL). The results indicated that various types of papillomas were produced in proportion to the dose applied to DMBA, B(a)P, and BPL. Certain of these papillomas were nonregressible and progressed readily to carcinomas; others regressed and did not progress to cancer. Multiple doses of DMBA and B(a)P produced carcinomas without an antecedent papilloma stage. The latter cancers were produced in proportion to the 2nd or 3rd power of applied carcinogen dose and were accelerated strongly by concomitant action of a promoter. Certain nonregressible papillomas probably represent the first step in a two or three step progression to cancer, although cancers from papillomas occur in proportion to dose.
本文提出了一种分析方法,用于评估引发剂、促癌剂和致癌物的效力,该方法基于在适当溶剂中将化合物局部涂抹于小鼠皮肤时,肿瘤数量随剂量和时间的变化情况。将给定化合物作为引发剂(单次给药后长期促癌)、完整致癌物(长时间多次给药)和辅助致癌物(长时间多次给药并结合促癌)进行测试。所测试的化合物有7,12 - 二甲基苯并(a)蒽(DMBA)、苯并(a)芘(B(a)P)、4 - 硝基喹啉 - 1 - 氧化物(4 - NQO)和β - 丙内酯(BPL)。结果表明,不同类型的乳头状瘤与应用于DMBA、B(a)P和BPL的剂量成比例产生。其中一些乳头状瘤不可消退,并容易发展为癌;另一些则消退且未发展为癌症。多次剂量的DMBA和B(a)P产生的癌无前驱乳头状瘤阶段。后一种癌症的产生与所应用致癌物剂量的平方或立方成比例,并受到促癌剂协同作用的强烈加速。某些不可消退的乳头状瘤可能代表了两到三步癌变过程的第一步,尽管由乳头状瘤发展而来的癌症与剂量成比例。